{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T10:33:03Z","timestamp":1784370783711,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.autrev.2017.02.012","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T01:00:14Z","timestamp":1487120414000},"page":"407-415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Towards developing criteria for scleroderma renal crisis: A scoping review"],"prefix":"10.1016","volume":"16","author":[{"given":"Sabrina","family":"Hoa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward P.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Denton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Frech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ghossein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Proudman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2017.02.012_bb0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.autrev.2016.01.007","article-title":"Systemic sclerosis: an update in 2016","volume":"15","author":"Desbois","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.02.012_bb0010","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.autrev.2015.07.012","article-title":"Quality of life in systemic sclerosis","volume":"14","author":"Almeida","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.02.012_bb0015","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.autrev.2016.01.016","article-title":"Genetic factors and systemic sclerosis","volume":"15","author":"Murdaca","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.02.012_bb0020","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of pulmonary complications and long-term survival in systemic sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2017.02.012_bb0025","first-page":"649","article-title":"Kidney disease other than renal crisis in patients with diffuse scleroderma","volume":"32","author":"Steen","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.02.012_bb0030","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.3899\/jrheum.111417","article-title":"Longitudinal study of renal function in systemic sclerosis","volume":"39","author":"Caron","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.02.012_bb0035","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.02.012_bb0040","first-page":"S29","article-title":"Assessment of kidney involvement","volume":"21","author":"Steen","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.02.012_bb0045","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.semarthrit.2013.09.008","article-title":"Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the international scleroderma renal crisis survey","volume":"43","author":"Hudson","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.02.012_bb0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Soc Res Methodol"},{"key":"10.1016\/j.autrev.2017.02.012_bb0055","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/jrsm.1123","article-title":"A scoping review of scoping reviews: advancing the approach and enhancing the consistency","volume":"5","author":"Pham","year":"2014","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.autrev.2017.02.012_bb0060","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3163\/1536-5050.104.3.014","article-title":"De-duplication of database search results for systematic reviews in EndNote","volume":"104","author":"Bramer","year":"2016","journal-title":"J Med Libr Assoc"},{"key":"10.1016\/j.autrev.2017.02.012_bb0065","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/art.30111","article-title":"HLA-DRB1 0407 and 1304 are risk factors for scleroderma renal crisis","volume":"63","author":"Nguyen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.02.012_bb0070","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00005792-198311000-00001","article-title":"Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases","volume":"62","author":"Traub","year":"1983","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2017.02.012_bb0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/03009742.2011.610032","article-title":"Scleroderma renal crisis in a Swedish systemic sclerosis cohort: survival, renal outcome, and RNA polymerase III antibodies as a risk factor","volume":"41","author":"Hesselstrand","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2017.02.012_bb0080","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0002-9343(84)90986-0","article-title":"Factors predicting development of renal involvement in progressive systemic sclerosis","volume":"76","author":"Steen","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2017.02.012_bb0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/annrheumdis-2014-205295","article-title":"Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study","volume":"75","author":"Avouac","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.02.012_bb0090","first-page":"135","article-title":"Effect of dihydropyridine calcium channel blockers and glucocorticoids on the prevention and development of scleroderma renal crisis in an Italian case series","volume":"31","author":"Montanelli","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.02.012_bb0095","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/rheumatology\/ker271","article-title":"Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls","volume":"51","author":"Guillevin","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.02.012_bb0100","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/hcm052","article-title":"Scleroderma renal crisis: patient characteristics and long-term outcomes","volume":"100","author":"Penn","year":"2007","journal-title":"QJM"},{"key":"10.1016\/j.autrev.2017.02.012_bb0105","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00124743-199708000-00003","article-title":"Scleroderma renal crisis analysis of prevalence and outcome in a large italian series","volume":"3","author":"Montagna","year":"1997","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.02.012_bb0110","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1002\/art.10589","article-title":"Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose d-penicillamine in early diffuse systemic sclerosis trial","volume":"46","author":"DeMarco","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.02.012_bb0115","article-title":"RNA polymerase III autoantibodies may indicate renal and more severe skin involvement in systemic sclerosis","volume":"24","author":"Terras","year":"2015","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2017.02.012_bb0120","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/art.38994","article-title":"Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies","volume":"67","author":"Hamaguchi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2017.02.012_bb0125","doi-asserted-by":"crossref","first-page":"R211","DOI":"10.1186\/ar3544","article-title":"Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort","volume":"13","author":"Nikpour","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2017.02.012_bb0130","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3899\/jrheum.091048","article-title":"Association of RNA polymerase III antibodies with scleroderma renal crisis","volume":"37","author":"Nguyen","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.02.012_bb0135","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1002\/art.39201","article-title":"Reply: to PMID 25512203","volume":"67","author":"Hamaguchi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2017.02.012_bb0140","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1046\/j.1445-5994.2003.00358.x","article-title":"Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment","volume":"33","author":"Walker","year":"2003","journal-title":"Intern Med J"},{"key":"10.1016\/j.autrev.2017.02.012_bb0145","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/bjd.13779","article-title":"A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis","volume":"173","author":"Takahashi","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2017.02.012_bb0150","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s10067-012-1949-9","article-title":"Increased serum soluble CD147 levels in patients with systemic sclerosis: association with scleroderma renal crisis","volume":"31","author":"Yanaba","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.02.012_bb0155","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1684\/ejd.2013.1924","article-title":"An inverse correlation of serum angiogenin levels with estimated glomerular filtration rate in systemic sclerosis patients with renal dysfunction","volume":"23","author":"Akamata","year":"2013","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.autrev.2017.02.012_bb0160","first-page":"1838","article-title":"Circulating endothelin-1 levels in systemic sclerosis subsets\u2013a marker of fibrosis or vascular dysfunction?","volume":"21","author":"Vancheeswaran","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.02.012_bb0165","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/ard.2006.066985","article-title":"Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients","volume":"67","author":"Teixeira","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.02.012_bb0170","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O","article-title":"Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis","volume":"41","author":"Steen","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.02.012_bb0175","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.semarthrit.2010.11.001","article-title":"Anti-neutrophil antibody associated vasculitis in systemic sclerosis","volume":"41","author":"Arad","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.02.012_bb0180","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s10067-012-2010-8","article-title":"Pauci-immune crescentic glomerulonephritis in limited cutaneous systemic sclerosis","volume":"31","author":"Chan","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.02.012_bb0185","first-page":"864","article-title":"Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis","volume":"21","author":"Endo","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.02.012_bb0190","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.2169\/internalmedicine.50.5653","article-title":"Thrombotic thrombocytopenic purpura with severe hypertension in a patient with systemic sclerosis sine scleroderma and polymyositis","volume":"50","author":"Iwagami","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2017.02.012_bb0195","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.semarthrit.2004.08.008","article-title":"Thrombotic thrombocytopenic purpura in the setting of systemic sclerosis","volume":"34","author":"Manadan","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.02.012_bb0200","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00124743-200104000-00011","article-title":"Thrombotic thrombocytopenia purpura in a patient with systemic sclerosis","volume":"7","author":"Yusin","year":"2001","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2017.02.012_bb0205","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4103\/0377-4929.120403","article-title":"Unusual case of pulmonary renal syndrome with autopsy findings","volume":"56","author":"Badwal","year":"2013","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.autrev.2017.02.012_bb0210","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.semarthrit.2015.06.017","article-title":"Oxalate nephropathy in systemic sclerosis: case series and review of the literature","volume":"45","author":"Ligon","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.02.012_bb0215","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5414\/CN108406","article-title":"An unusual cause of acute kidney injury due to oxalate nephropathy in systemic scleroderma","volume":"84","author":"Mascio","year":"2015","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.autrev.2017.02.012_bb0220","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1136\/ard.2002.002295","article-title":"An unusual cause of acute renal failure in systemic sclerosis","volume":"62","author":"Mpofu","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.02.012_bb0225","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2169\/internalmedicine.46.0118","article-title":"ACE inhibitor-induced acute renal failure in a patient with progressive systemic sclerosis: ischemic nephropathy mimicking PSS renal crisis","volume":"46","author":"Shinohara","year":"2007","journal-title":"Intern Med"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217300526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217300526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T11:44:20Z","timestamp":1601639060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997217300526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1568997217300526"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.02.012","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards developing criteria for scleroderma renal crisis: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}